c-IAP2 Antibodies

Santa Cruz Biotechnology provides a broad selection of c-IAP2 monoclonal antibodies for various research applications. c-IAP2 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). c-IAP2, or cellular inhibitor of apoptosis protein 2, plays a critical role in regulating apoptosis and cell survival, making it an important target in cancer research and therapeutic development. By inhibiting caspases, c-IAP2 contributes to the prevention of programmed cell death, which can lead to tumorigenesis when dysregulated. Understanding the function of c-IAP2 is essential for elucidating mechanisms of cancer progression and developing targeted therapies. Researchers worldwide utilize c-IAP2 monoclonal antibodies to investigate cellular pathways involved in programmed cell death. Advanced research in c-IAP2 signaling pathways continues to reveal new insights into cancer biology and potential therapeutic strategies. The high-quality monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding of apoptosis regulation and its role in disease development.